214 related articles for article (PubMed ID: 15184366)
1. Two variable regions in carcinoembryonic antigen-related cell adhesion molecule1 N-terminal domains located in or next to monoclonal antibody and adhesion epitopes show evidence of recombination in rat but not in human.
Comegys MM; Lin SH; Rand D; Britt D; Flanagan D; Callanan H; Brilliant K; Hixson DC
J Biol Chem; 2004 Aug; 279(33):35063-78. PubMed ID: 15184366
[TBL] [Abstract][Full Text] [Related]
2. Homophilic adhesion of human CEACAM1 involves N-terminal domain interactions: structural analysis of the binding site.
Watt SM; Teixeira AM; Zhou GQ; Doyonnas R; Zhang Y; Grunert F; Blumberg RS; Kuroki M; Skubitz KM; Bates PA
Blood; 2001 Sep; 98(5):1469-79. PubMed ID: 11520797
[TBL] [Abstract][Full Text] [Related]
3. Identification of allelic variants of the bovine immune regulatory molecule CEACAM1 implies a pathogen-driven evolution.
Kammerer R; Popp T; Singer BB; Schlender J; Zimmermann W
Gene; 2004 Sep; 339():99-109. PubMed ID: 15363850
[TBL] [Abstract][Full Text] [Related]
4. Carcinoembryonic antigen cell adhesion molecule 1 directly associates with cytoskeleton proteins actin and tropomyosin.
Schumann D; Chen CJ; Kaplan B; Shively JE
J Biol Chem; 2001 Dec; 276(50):47421-33. PubMed ID: 11595750
[TBL] [Abstract][Full Text] [Related]
5. The transmembrane domain of CEACAM1-4S is a determinant of anchorage independent growth and tumorigenicity.
Lawson EL; Mills DR; Brilliant KE; Hixson DC
PLoS One; 2012; 7(1):e29606. PubMed ID: 22235309
[TBL] [Abstract][Full Text] [Related]
6. The cell adhesion molecule CEACAM1-L is a substrate of caspase-3-mediated cleavage in apoptotic mouse intestinal cells.
Houde C; Roy S; Leung N; Nicholson DW; Beauchemin N
J Biol Chem; 2003 May; 278(19):16929-35. PubMed ID: 12637508
[TBL] [Abstract][Full Text] [Related]
7. The cytoplasmic domain of CEACAM1-L controls its lateral localization and the organization of desmosomes in polarized epithelial cells.
Sundberg U; Beauchemin N; Obrink B
J Cell Sci; 2004 Mar; 117(Pt 7):1091-104. PubMed ID: 14970258
[TBL] [Abstract][Full Text] [Related]
8. Synthetic peptides from the N-domains of CEACAMs activate neutrophils.
Skubitz KM; Campbell KD; Skubitz AP
J Pept Res; 2001 Dec; 58(6):515-26. PubMed ID: 12005421
[TBL] [Abstract][Full Text] [Related]
9. Coevolution of activating and inhibitory receptors within mammalian carcinoembryonic antigen families.
Kammerer R; Zimmermann W
BMC Biol; 2010 Feb; 8():12. PubMed ID: 20132533
[TBL] [Abstract][Full Text] [Related]
10. Carcinoembryonic antigen-related cell adhesion molecule 1 expression and signaling in human, mouse, and rat leukocytes: evidence for replacement of the short cytoplasmic domain isoform by glycosylphosphatidylinositol-linked proteins in human leukocytes.
Singer BB; Scheffrahn I; Heymann R; Sigmundsson K; Kammerer R; Obrink B
J Immunol; 2002 May; 168(10):5139-46. PubMed ID: 11994468
[TBL] [Abstract][Full Text] [Related]
11. Secreted CEACAM1 splice variants in rat cell lines and in vivo in rat serum.
Budt M; Michely B; Müller MM; Reutter W; Lucka L
Biochem Biophys Res Commun; 2002 Apr; 292(3):749-55. PubMed ID: 11922629
[TBL] [Abstract][Full Text] [Related]
12. Species-specific evolution of immune receptor tyrosine based activation motif-containing CEACAM1-related immune receptors in the dog.
Kammerer R; Popp T; Härtle S; Singer BB; Zimmermann W
BMC Evol Biol; 2007 Oct; 7():196. PubMed ID: 17945019
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of the cytoplasmic domain of CEACAM1-4L in humanized mammary glands reveals key residues involved in lumen formation: stimulation by Thr-457 and inhibition by Ser-461.
Li C; Chen CJ; Shively JE
Exp Cell Res; 2009 Apr; 315(7):1225-33. PubMed ID: 19146852
[TBL] [Abstract][Full Text] [Related]
14. Soluble isoforms of CEACAM1 containing the A2 domain: increased serum levels in patients with obstructive jaundice and differences in 3-fucosyl-N-acetyl-lactosamine moiety.
Dráberová L; Cerná H; Brodská H; Boubelík M; Watt SM; Stanners CP; Dráber P
Immunology; 2000 Oct; 101(2):279-87. PubMed ID: 11012782
[TBL] [Abstract][Full Text] [Related]
15. Characterization of recombinant soluble carcinoembryonic antigen cell adhesion molecule 1.
Schumann D; Huang J; Clarke PE; Kirshner J; Tsai SW; Schumaker VN; Shively JE
Biochem Biophys Res Commun; 2004 May; 318(1):227-33. PubMed ID: 15110777
[TBL] [Abstract][Full Text] [Related]
16. Identification of Lewis x structures of the cell adhesion molecule CEACAM1 from human granulocytes.
Lucka L; Fernando M; Grunow D; Kannicht C; Horst AK; Nollau P; Wagener C
Glycobiology; 2005 Jan; 15(1):87-100. PubMed ID: 15317738
[TBL] [Abstract][Full Text] [Related]
17. Identification of the ligand-binding domains of CD22, a member of the immunoglobulin superfamily that uniquely binds a sialic acid-dependent ligand.
Engel P; Wagner N; Miller AS; Tedder TF
J Exp Med; 1995 Apr; 181(4):1581-6. PubMed ID: 7535343
[TBL] [Abstract][Full Text] [Related]
18. Carcinoembryonic antigen-related cell adhesion molecule 1a-4L suppression of rat hepatocellular carcinomas.
Laurie NA; Comegys MM; Carreiro MP; Brown JF; Flanagan DL; Brilliant KE; Hixson DC
Cancer Res; 2005 Dec; 65(23):11010-7. PubMed ID: 16322250
[TBL] [Abstract][Full Text] [Related]
19. Differences in tissue-specific and embryonic expression of mouse Ceacam1 and Ceacam2 genes.
Han E; Phan D; Lo P; Poy MN; Behringer R; Najjar SM; Lin SH
Biochem J; 2001 Apr; 355(Pt 2):417-23. PubMed ID: 11284729
[TBL] [Abstract][Full Text] [Related]
20. The critical role of residues 43R and 44Q of carcinoembryonic antigen cell adhesion molecules-1 in the protection from killing by human NK cells.
Markel G; Gruda R; Achdout H; Katz G; Nechama M; Blumberg RS; Kammerer R; Zimmermann W; Mandelboim O
J Immunol; 2004 Sep; 173(6):3732-9. PubMed ID: 15356119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
